International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O’Mahony, Perry Elliott, Israel Gotsman et al.|Circulation|2017Cited by 209
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Rumana Omar, Constantin‐Cristian Topriceanu et al.|European Journal of Preventive Cardiology|2021Cited by 35
Association of Multiple Nonhypertrophic Cardiomyopathy–Related Genetic Variants and Outcomes in Patients With Hypertrophic CardiomyopathyTakashi Hiruma, Issei Komuro, Shunsuke Inoue et al.|JACC Heart Failure|2024Cited by 8
Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registryToru Kubo, Hiroaki Kitaoka, Kenta Sugiura et al.|Heart|2025Cited by 3
Validation of the 2018 Japanese Circulation Society (JCS)/Japanese Heart Failure Society (JHFS) Guidelines for Preventing Sudden Cardiac Death in Patients With Hypertrophic CardiomyopathyMasashi Amano, Hiroaki Kitaoka, Yusuke Yoshikawa et al.|Circulation Journal|2025Cited by 1